Chief of Myeloma Service, Memorial Sloan Kettering Cancer CenterBiography
Dr. Ola Landgren gained his MD in 1995 from Karolinska Institute, Stockholm, Sweden. Currently, Dr. Landgren is Chief of Myeloma Service at Memorial Sloan-Kettering Cancer Center in New York, NY. He holds a PhD in Diagnostics and Prognostics in Lymphoid Malignancies from Karolinska Institute, Stockholm, Sweden. He has published over 300 papers including a definitive prospective cancer screening study showing that myeloma is consistently preceded by a precursor state. Since 2007, Dr Landgren's translational research has particularly focused on the development of early treatment in smoldering myeloma and newly diagnosed multiple myeloma, paired with cell-based and molecular-based minimal residual disease (MRD) monitoring.